Radiomics machine learning algorithm facilitates detection of small pancreatic neuroendocrine tumors on CT

被引:0
|
作者
Lopez-Ramirez, Felipe [1 ]
Soleimani, Sahar [1 ]
Azadi, Javad R. [1 ]
Sheth, Sheila [1 ,2 ]
Kawamoto, Satomi [1 ]
Javed, Ammar A. [3 ]
Tixier, Florent [1 ]
Hruban, Ralph H. [4 ,5 ]
Fishman, Elliot K. [1 ]
Chu, Linda C. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[2] NYU, Grossman Sch Med, Dept Radiol, New York, NY 10016 USA
[3] NYU, Grossman Sch Med, Dept Surg, New York, NY 10016 USA
[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Sch Med, Dept Pathol, Baltimore, MD 21287 USA
关键词
Artificial intelligence; Automated screening; Computed tomography; Pancreatic neuroendocrine tumors; Radiomics; SEGMENTATION;
D O I
10.1016/j.diii.2024.08.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this study was to develop a radiomics-based algorithm to identify small pancreatic neuroendocrine tumors (PanNETs) on CT and evaluate its robustness across manual and automated segmentations, exploring the feasibility of automated screening. Materials and methods: Patients with pathologically confirmed T1 stage PanNETs and healthy controls undergoing dual-phase CT imaging were retrospectively identified. Manual segmentation of pancreas and tumors was performed, then automated pancreatic segmentations were generated using a pretrained neural network. A total of 1223 radiomics features were independently extracted from both segmentation volumes, in the arterial and venous phases separately. Ten final features were selected to train classifiers to identify PanNETs and controls. The cohort was divided into training and testing sets, and performance of classifiers was assessed using area under the receiver operator characteristic curve (AUC), specificity and sensitivity, and compared against two radiologists blinded to the diagnoses. Results: A total of 135 patients with 142 PanNETs, and 135 healthy controls were included. There were 168 women and 102 men, with a mean age of 55.4 11.6 (standard deviation) years (range: 20-85 years). Median PanNET size was 1.3 cm (Q1, 1.0; Q3, 1.5; range: 0.5-1.9). The arterial phase LightGBM model achieved the best performance in the test set, with 90% sensitivity (95% confidence interval [CI]: 80-98), 76% specificity (95% CI: 62-88) and an AUC of 0.87 (95% CI: 0.79-0.94). Using features from the automated segmentations, this model achieved an AUC of 0.86 (95% CI: 0.79-0.93). In comparison, the two radiologists achieved a mean 50% sensitivity and 100% specificity using arterial phase CT images. Conclusion: Radiomics features identify small PanNETs, with stable performance when extracted using automated segmentations. These models demonstrate high sensitivity, complementing the high specificity of radiologists, and could serve as opportunistic screeners. (c) 2024 Soci & eacute;t & eacute; fran & ccedil;aise de radiologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 50 条
  • [41] Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors
    Raoof, Mustafa
    Jutric, Zeljka
    Melstrom, Laleh G.
    Lee, Byrne
    Li, Daneng
    Warner, Susanne G.
    Fong, Yuman
    Singh, Gagandeep
    SURGERY, 2019, 165 (04) : 760 - 766
  • [42] Small Pancreatic and Periampullary Neuroendocrine Tumors: Resect or Enucleate?
    Susan C. Pitt
    Henry A. Pitt
    Marshall S. Baker
    Kathleen Christians
    John G. Touzios
    James M. Kiely
    Sharon M. Weber
    Stuart D. Wilson
    Thomas J. Howard
    Mark S. Talamonti
    Layton F. Rikkers
    Journal of Gastrointestinal Surgery, 2009, 13 : 1692 - 1698
  • [43] Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
    Scott, Aaron T.
    Hernandez, Matthew C.
    Lewis, Aaron
    Li, Daneng
    Melstrom, Laleh
    Singh, Gagandeep
    Fong, Yuman
    Raoof, Mustafa
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S70 - S70
  • [44] Prognostic Significance of Chromogranin A in Small Pancreatic Neuroendocrine Tumors
    Raoof, M.
    Jutric, Z.
    Melstrom, L.
    Warner, S.
    Woo, Y.
    Fong, Y.
    Singh, G.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S122 - S123
  • [45] A CT- based radiomics and deep learning signature for evaluating the somatostatin receptor 2 in non-functional pancreatic neuroendocrine tumors: A multicohort, retrospective study
    Tang, W.
    Wenchao, G.
    Yinli, C.
    Jie, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 192 - 192
  • [46] Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors
    Vogele, Daniel
    Mueller, Teresa
    Wolf, Daniel
    Otto, Stephanie
    Manoj, Sabitha
    Goetz, Michael
    Ettrich, Thomas J.
    Beer, Meinrad
    DIAGNOSTICS, 2024, 14 (02)
  • [47] Detection of pancreatic neuroendocrine tumors: 23 years of experience
    Varas-Lorenzo, M. J.
    Cugat, E.
    Capdevila, J.
    Sanchez-Vizcaino Mengual, E.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2019, 84 (01): : 18 - 25
  • [48] Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model
    Ahmed, Taha M.
    Zhu, Zhuotun
    Yasrab, Mohammad
    Blanco, Alejandra
    Kawamoto, Satomi
    He, Jin
    Fishman, Elliot K.
    Chu, Linda
    Javed, Ammar A.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8136 - 8145
  • [49] CT findings of non-functioning neuroendocrine pancreatic tumors
    Secil, M
    Goktay, AY
    Oksuzler, Y
    Sagol, O
    Dicle, O
    Igci, E
    Pirnar, T
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2002, 26 (01) : 43 - 45
  • [50] Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
    Calabro, Diletta
    Argalia, Giulia
    Ambrosini, Valentina
    DIAGNOSTICS, 2020, 10 (12)